Treace Medical Concepts 第四季度每股收益$(0.01),超出$(0.04)的预期,销售额$6871万,超出$6716万的预期

财报速递2025-02-28
Treace Medical Concepts (NASDAQ:TMCI) 公布其季度每股亏损$(0.01),比分析师普遍预期的$(0.04)高出75%。与去年同期每股亏损$(0.10)相比,增长了90%。公司公告季度销售额为$6871万,比分析师普遍预期的$6716万高出2.31%。与去年同期的$6221万相比,增长了10.44%。

以上内容来自Benzinga Earnings专栏,原文如下:

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 90 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $68.71 million which beat the analyst consensus estimate of $67.16 million by 2.31 percent. This is a 10.44 percent increase over sales of $62.21 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法